Sandler AB - Search Results

1

A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study.

Ganjoo KN, Gordon MS, Sandler AB, Warner RE, Fife K, Poirier S, Seshadri R, Loehrer PJ. Ganjoo KN, et al. Among authors: sandler ab. Oncology. 2002;62(4):299-304. doi: 10.1159/000065060. Oncology. 2002. PMID: 12138236 Clinical Trial.

2

Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies.

Hanna NH, Gordon MS, Fife K, Sandler AB. Hanna NH, et al. Among authors: sandler ab. Am J Clin Oncol. 2002 Aug;25(4):337-9. doi: 10.1097/00000421-200208000-00002. Am J Clin Oncol. 2002. PMID: 12151959 Clinical Trial.

3

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.

Faylona EA, Loehrer PJ, Ansari R, Sandler AB, Gonin R, Einhorn LH. Faylona EA, et al. Among authors: sandler ab. J Clin Oncol. 1995 May;13(5):1209-14. doi: 10.1200/JCO.1995.13.5.1209. J Clin Oncol. 1995. PMID: 7738623 Clinical Trial.

4

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.

Loehrer PJ Sr, Ansari R, Gonin R, Monaco F, Fisher W, Sandler A, Einhorn LH. Loehrer PJ Sr, et al. J Clin Oncol. 1995 Oct;13(10):2594-9. doi: 10.1200/JCO.1995.13.10.2594. J Clin Oncol. 1995. PMID: 7595712 Clinical Trial.

5

Paclitaxel plus gallium nitrate and filgrastim in patients with refractory malignancies: a phase I trial.

Sandler A, Fox S, Meyers T, Christou A, Weber G, Gonin R, Loehrer PJ, Einhorn LH, Dreicer R. Sandler A, et al. Am J Clin Oncol. 1998 Apr;21(2):180-4. doi: 10.1097/00000421-199804000-00018. Am J Clin Oncol. 1998. PMID: 9537208 Clinical Trial.

6

A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.

Sandler A, Gordon M, De Alwis DP, Pouliquen I, Green L, Marder P, Chaudhary A, Fife K, Battiato L, Sweeney C, Jordan C, Burgess M, Slapak CA. Sandler A, et al. Clin Cancer Res. 2004 May 15;10(10):3265-72. doi: 10.1158/1078-0432.CCR-03-0644. Clin Cancer Res. 2004. PMID: 15161679 Clinical Trial.

7

A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.

Ng EW, Sandler AB, Robinson L, Einhorn LH. Ng EW, et al. Among authors: sandler ab. Am J Clin Oncol. 1999 Dec;22(6):550-3. doi: 10.1097/00000421-199912000-00003. Am J Clin Oncol. 1999. PMID: 10597737 Clinical Trial.

8

Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency.

Hata Y, Sandler A, Loehrer PJ, Sledge GW Jr, Weber G. Hata Y, et al. Oncol Res. 1994;6(1):19-24. Oncol Res. 1994. PMID: 7919548

9

Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.

Zon RT, McClean J, Helman D, Ansari R, Picus J, Sandler A, Williams SD, Loehrer PJ Sr. Zon RT, et al. Invest New Drugs. 2001;19(3):229-31. doi: 10.1023/a:1010620601431. Invest New Drugs. 2001. PMID: 11561679 Clinical Trial.

10

Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.

Sweeney CJ, Takimoto CH, Latz JE, Baker SD, Murry DJ, Krull JH, Fife K, Battiato L, Cleverly A, Chaudhary AK, Chaudhuri T, Sandler A, Mita AC, Rowinsky EK. Sweeney CJ, et al. Clin Cancer Res. 2006 Jan 15;12(2):536-42. doi: 10.1158/1078-0432.CCR-05-1834. Clin Cancer Res. 2006. PMID: 16428497 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters